Charles “Chuck” Love is the founder and CEO of Venture Sciences Group (VSG). Prior to VSG, Chuck held strategic executive roles for companies pursing cutting-edge medical technologies including the Medtronic CoreValve transcatheter heart valve, Circulite Synergy ventricular assist system, and Endologix Nellix AAA graft. He holds seminal patents in the field of cardiac and vascular surgery. In addition to his employment history, Chuck has been an active investor, advisor and board member to a number of exiting med-tech start-ups including Loma vista Medical and LimFlow. He brings over three decades of experience to his companies offering a unique combination technical and clinical skills. Chuck studied mechanical engineering at Gonzaga University, holds a BA in Biology from Westmont College, and completed an executive business program through Stanford University.